TickerFacts.

Endonovo Therapeutics, Inc. (ENDV): Operating Income

Annual figures by period end, from SEC filings.

Not updated since 2022-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

-$3.26M
Year ended 2022-12-31
2010-12-31: -$78.0K2011-12-31: -$95.5K2012-12-31: -$1.74M2013-12-31: -$2.43M2014-12-31: -$2.19M2015-12-31: -$2.56M2016-12-31: -$5.41M2017-12-31: -$4.60M2018-12-31: -$4.16M2019-12-31: -$3.81M2020-12-31: -$2.91M2021-12-31: -$2.23M2022-12-31: -$3.26M-$3.26M
2010-12-31 Operating Income (USD) 2022-12-31
Period endedOperating IncomeChange YoYSource filing
2022-12-31-$3.26Mn/m2023-04-17, From 2022-01-01
2021-12-31-$2.23Mn/m2023-04-17, From 2021-01-01
2020-12-31-$2.91Mn/m2022-04-14, From 2020-01-01
2019-12-31-$3.81Mn/m2021-04-13, From 2019-01-01
2018-12-31-$4.16Mn/m2020-05-04, From 2018-01-01
2017-12-31-$4.60Mn/m2019-04-15, From 2017-01-01
2016-12-31-$5.41Mn/m2018-04-06, From 2016-01-01
2015-12-31-$2.56Mn/m2017-04-17, From 2015-01-01
2014-12-31-$2.19Mn/m2016-05-17, From 2014-01-01
2013-12-31-$2.43Mn/m2015-06-15, From 2013-01-01
2012-12-31-$1.74Mn/m2013-05-03, From 2012-01-01
2011-12-31-$95.5Kn/m2012-04-13, From 2011-01-01
2010-12-31-$78.0Kn/a2012-04-13, From 2010-01-01